Factor I: Difference between revisions
CSV import |
CSV import |
||
| Line 30: | Line 30: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 11:55, 17 March 2025
Factor I is a protein in the blood that plays a crucial role in the immune system. It is part of the complement system, a group of proteins that work together to destroy foreign invaders (such as bacteria and viruses), trigger inflammation, and remove debris from cells and tissues.
Factor I is specifically involved in the regulation of the complement system. It helps to prevent the system from becoming overactive and causing damage to the body's own cells and tissues. Factor I does this by inactivating two proteins in the complement system, known as C3b and C4b. These proteins are involved in a series of reactions that lead to the destruction of foreign invaders.
Structure and Function[edit]
Factor I is a glycoprotein that is produced in the liver and circulates in the blood. It is made up of two chains, a heavy chain and a light chain, which are linked together by disulfide bonds. The heavy chain contains a region known as the serine protease domain, which is responsible for the protein's enzymatic activity.
Factor I functions as a serine protease, an enzyme that cuts other proteins at specific sites. It cleaves C3b and C4b, inactivating them and preventing them from participating in the complement cascade. This helps to regulate the activity of the complement system and prevent it from causing damage to the body's own cells and tissues.
Clinical Significance[edit]
Mutations in the CFI gene, which provides instructions for making Factor I, can lead to a deficiency of this protein. This can result in uncontrolled activation of the complement system, leading to damage to the body's own cells and tissues. Factor I deficiency is associated with a number of health problems, including atypical hemolytic uremic syndrome (aHUS), age-related macular degeneration (AMD), and certain types of kidney disease.
Treatment for Factor I deficiency typically involves managing the symptoms and complications of the condition. This may include plasma therapy to replace the missing or malfunctioning Factor I, or medications to inhibit the activity of the complement system.
